Sowell Financial Services LLC Geron Corp Transaction History

Sowell Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.14 - $3.4 $36,380 - $57,800	17,000 New	17,000 $36,000
Q2 2021 Aug 05, 2021	SELL	$1.25 - $1.83 $23,750 - $34,770	-19,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $17,850 - $37,060	17,000 Added 850.0%	19,000 $41,000
Q1 2020 May 12, 2020	BUY	$0.89 - $1.49 $1,780 - $2,980	2,000 New	2,000 $2,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.53B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.